학술논문
Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma
Document Type
Article
Author
Wu, Y.; Chen, S.; Yang, X.; Sato, K.; Lal, P.; Shinkle, A.T.; Wendl, M.C.; Primeau, T.M.; Zhao, Y.; Gould, A.; Sun, H.; Mudd, J.L.; Hoog, J.; Mashl, R.J.; Wyczalkowski, M.A.; Mo, C.-K.; Liu, R.; Davies, S.R.; Liu, D.; Ding, X.; Govindan, R.; Li, S.; Hsieh, J.; Lim, K.-H.; Ma, C.X.; Ding, L.; Chen, F.; Wang, Y.; Zhang, H.; Fields, R.C.; Herndon, J.M.; Evrard, Y.A.; Welm, B.E.; Lum, D.; Koh, M.Y.; Welm, A.L.; Chuang, J.H.; Moscow, J.A.; Meric-Bernstam, F.
Source
In: Cancer Research . (Cancer Research, 15 December 2023, 183(24):4161-4178)
Subject
Language
English
ISSN
15387445
00085472
00085472